Paxton Accuses Companies of Deceptive Marketing
Texas Attorney General Ken Paxton has filed a lawsuit against Johnson & Johnson and its spinoff Kenvue Inc., accusing the companies of deceptively marketing Tylenol to pregnant women while allegedly concealing potential links to autism and other developmental disorders.
“Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks,” Paxton said in a statement Tuesday. “By holding Big Pharma accountable for poisoning our people, we will help Make America Healthy Again.”
First State Lawsuit Following Trump’s Claim
This marks the first state-level lawsuit since former President Donald Trump publicly claimed that Tylenol use during pregnancy increases the risk of autism—an assertion that medical experts say lacks credible scientific evidence.
Background on the Companies
Johnson & Johnson sold Tylenol for decades before transferring ownership of its consumer health division to Kenvue in 2023. Both companies are now named defendants in the Texas lawsuit.
Kenvue Responds, Defends Acetaminophen’s Safety
In a statement, Kenvue rejected Paxton’s allegations, calling them “baseless” and warning that spreading misinformation about acetaminophen could harm pregnant women and their babies.
“Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy,” the company said.
“Without it, women face dangerous choices: suffer through high fevers or pain that can harm both mother and baby, or turn to riskier alternatives.”
Kenvue added that it plans to vigorously defend itself in court, maintaining that the claims “lack legal merit and scientific support.”
For more Texas news, stay tuned to Que Onda Magazine.